Form D Explorer

Form D — Aeovian Pharmaceuticals, Inc.

0000905148-25-004456 · filed 2025-12-22

Offering

Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $54,999,996
Total sold: $54,999,996
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Aeovian Pharmaceuticals, Inc.
CIK: 1710088
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 2930 Domingo Ave., Suite 145
Berkeley, CA 94705
Phone: 510-961-1148

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Allison J. Hulme · Executive Officer

Berkeley, CA Find on LinkedIn ↗
Micah Zajic · Executive Officer

Berkeley, CA Find on LinkedIn ↗
William Greene · Director

Berkeley, CA Find on LinkedIn ↗
Justin Gover · Director

Berkeley, CA Find on LinkedIn ↗
Richard Gaster · Director

Berkeley, CA Find on LinkedIn ↗
Lars Ekman · Director

Berkeley, CA Find on LinkedIn ↗
Nils Regge · Director

Berkeley, CA Find on LinkedIn ↗
Themasap Khan · Director

Berkeley, CA Find on LinkedIn ↗
Youssef Bennani · Director

Berkeley, CA Find on LinkedIn ↗
John Kincaid · Executive Officer

Berkeley, CA Find on LinkedIn ↗
Davis Ryman · Executive Officer

Berkeley, CA Find on LinkedIn ↗

View original on SEC EDGAR.